Zobrazeno 1 - 2
of 2
pro vyhledávání: '"MESH: Interferon beta-1a / therapeutic use"'
Autor:
Chadia Ed‐driouch, Florent Chéneau, Françoise Simon, Guillaume Pasquier, Benoit Combès, Anne Kerbrat, Emmanuelle Le Page, Sophie Limou, Nicolas Vince, David‐Axel Laplaud, Franck Mars, Cédric Dumas, Gilles Edan, Pierre‐Antoine Gourraud
Publikováno v:
Annals of Clinical and Translational Neurology
Annals of Clinical and Translational Neurology, 2022, 9 (12), pp.1863-1873. ⟨10.1002/acn3.51649⟩
Annals of Clinical and Translational Neurology, 2022, 9 (12), pp.1863-1873. ⟨10.1002/acn3.51649⟩
International audience; Objective: Multiple sclerosis (MS) is a multifactorial disease with increasingly complicated management. Our objective is to use on-demand computational power to address the challenges of dynamically managing MS.Methods: A pha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0344e51453a7dc5208d4f2246e8cc8ac
https://pubmed.ncbi.nlm.nih.gov/36412095
https://pubmed.ncbi.nlm.nih.gov/36412095
Autor:
Lionel Piroth, Bruno Mourvillier, Joy Mootien, François-Xavier Lescure, Emmanuel Faure, S. Gallien, Dominique Costagliola, Jean-Christophe Richard, Noemie Mercier, Florent Wallet, Yazdan Yazdanpanah, Marion Noret, Claire Andrejak, Jean-Philippe Lanoix, Julien Poissy, Johan Courjon, Saad Nseir, François Danion, Violaine Tolsma, Alain Makinson, Odile Launay, Raphaël Clere-Jehl, Bruno Lina, Drifa Belhadi, Valérie Pourcher, Antoine Kimmoun, Karine Lacombe, Juliette Saillard, Maude Bouscambert-Duchamp, Stéphane Jauréguiberry, Charles Burdet, Toni Alfaiate, Olivier Epaulard, Minh Patrick Lê, Gilles Peytavin, Elisabeth Botelho-Nevers, Thérèse Staub, Guillaume Martin-Blondel, Alpha Diallo, Lila Bouadma, Aline Dechanet, François Goehringer, Florence Ader, Nathan Peiffer-Smadja, Jean-Christophe Navellou, Christelle Delmas, Rostane Gaci, Kevin Bouiller, Maya Hites, André Cabié, Jean Reuter, Sylvie Leroy, Axelle Dupont, François Raffi, Amandine Gagneux-Brunon, Jean Reignier, Clément Dubost
Publikováno v:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, S1198-743X (21), pp.00259-7. ⟨10.1016/j.cmi.2021.05.020⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, 27 (12), pp.1826-1837. ⟨10.1016/j.cmi.2021.05.020⟩
Clinical Microbiology and Infection, 2021, 27 (12), pp.1826-1837. ⟨10.1016/j.cmi.2021.05.020⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, S1198-743X (21), pp.00259-7. ⟨10.1016/j.cmi.2021.05.020⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2021, 27 (12), pp.1826-1837. ⟨10.1016/j.cmi.2021.05.020⟩
Clinical Microbiology and Infection, 2021, 27 (12), pp.1826-1837. ⟨10.1016/j.cmi.2021.05.020⟩
International audience; Objectives: We evaluated the clinical, virological and safety outcomes of lopinavir/ritonavir, lopinavir/ritonavir-interferon (IFN)-β-1a, hydroxychloroquine or remdesivir in comparison to standard of care (control) in coronav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a8dd207add00814d32d637b7eef3ab
https://hal.archives-ouvertes.fr/hal-03364426
https://hal.archives-ouvertes.fr/hal-03364426
